ArticleWorld journal of clinical cases2022

Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.

Qian-Qian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.